Premium
Effect of Mammalian Cell Differentiation on Response to Exogenous 5‐Aminolevulinic Acid
Author(s) -
Li Ge,
Szewczuk Myron R.,
Pottier Roy H.,
Kennedy James C.
Publication year - 1999
Publication title -
photochemistry and photobiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.818
H-Index - 131
eISSN - 1751-1097
pISSN - 0031-8655
DOI - 10.1111/j.1751-1097.1999.tb03279.x
Subject(s) - promyelocyte , cellular differentiation , cell culture , in vitro , cell type , leukemia , chemistry , phenotype , cell , differentiation therapy , microbiology and biotechnology , in vivo , protoporphyrin ix , biology , cancer research , biochemistry , acute promyelocytic leukemia , retinoic acid , immunology , photodynamic therapy , genetics , organic chemistry , gene
Abstract— Many different types of mammalian cells accumulate fluorescing and photosensitizing concentrations of protoporphyrin IX (PpIX) when exposed to exogenous 5‐aminolevulinic acid (ALA) in vivo or in vitro. Most types of malignant cells accumulate substantially more ALA‐induced PpIX than do the normal cells from which they arose. Most types of malignant cells also are less differentiated than their normal counterparts. We therefore considered the possibility that malignant cells demonstrate a malignant ALA phenotype (accumulate abnormally large amounts of PpIX when exposed to exogenous ALA) as a direct consequence of their less differentiated state. Human promyelocyte cell line HL‐60 and mouse preadipocyte cell line 3T3 L1 were induced to differentiate by exposing them to inducing agents in vitro. The HL‐60 cells accumulated less ALA‐induced PpIX when differentiated, but the 3T3 L1 cells accumulated more. It appears then that changes in the ALA phenotype with changes in the state of differentiation are cell‐type specific. The decreased accumulation of ALA‐induced PpIX that accompanied differentiation of the promyelocytic leukemia cells may have clinical application for rapid quantitation of the response of myelocytic leukemia patients to differentiation therapy.